Enhanced nuclear translocation and activation of aryl hydrocarbon receptor (AhR) in THP-1 monocytic cell line by a novel niosomal formulation of indole-3-carbinol

References

• Abdelbary, G. and El-Gendy, N., 2008. Niosome-encapsulated gentamicin for ophthalmic controlled delivery. Aaps pharmscitech, 9 (3), 740–747.
   PubMed Web of Science ®Google Scholar
• Aggarwal, B.B. and Ichikawa, H., 2005. Molecular targets and anticancer potential of indole-3-carbinol and its derivatives. Cell cycle, 4 (9), 1201–1215.
   PubMed Web of Science ®Google Scholar
• Ashida, H., et al., 2000. Flavones and flavonols at dietary levels inhibit a transformation of aryl hydrocarbon receptor induced by dioxin. FEBS letters, 476 (3), 213–217.
   PubMed Web of Science ®Google Scholar
• Bayindir, Z.S. and Yuksel, N., 2010. Characterization of niosomes prepared with various nonionic surfactants for paclitaxel oral delivery. Journal of pharmaceutical sciences, 99 (4), 2049–2060.
   PubMed Web of Science ®Google Scholar
• Bera, B., 2015. Nanoporous silicon prepared by vapour phase strain etch and sacrificial technique. Proceedings of the International Conference on Microelectronic Circuit and System (Micro), 2015 Kolkata, India, 42–45.
   Google Scholar
• Bragagni, M., et al., 2012. Development and characterization of niosomal formulations of doxorubicin aimed at brain targeting. Journal of pharmacy & pharmaceutical sciences, 15, 184–196.
   PubMed Web of Science ®Google Scholar
• Celius, T. and Matthews, J., 2010. Functional analysis of six human aryl hydrocarbon receptor variants in human breast cancer and mouse hepatoma cell lines. Toxicology, 277 (1–3), 59–65.
   PubMed Web of Science ®Google Scholar
• Costa, P. and Lobo, J.M.S., 2001. Modeling and comparison of dissolution profiles. European Journal of pharmaceutical sciences, 13 (2), 123–133.
   PubMed Web of Science ®Google Scholar
• Dash, S., et al., 2010. Kinetic modeling on drug release from controlled drug delivery systems. Acta poloniae pharmaceutica, 67 (3), 217–223.
   PubMed Web of Science ®Google Scholar
• Davis, M.E., Chen, Z., and Shin, D.M., 2008. Nanoparticle therapeutics: an emerging treatment modality for cancer. Nature reviews drug discovery, 7 (9), 771.
   PubMed Web of Science ®Google Scholar
• Edwards, G. and Krishna, S., 2004. Pharmacokinetic and pharmacodynamic issues in the treatment of parasitic infections. European journal of clinical microbiology and infectious diseases, 23 (4), 233–242.
   PubMed Web of Science ®Google Scholar
• Faust, D., et al., 2013. Aryl hydrocarbon receptor-dependent cell cycle arrest in isolated mouse oval cells. Toxicology letters, 223 (1), 73–80.
   PubMed Web of Science ®Google Scholar
• Gradelet, S., et al., 1997. Ah receptor-dependent CYP1A induction by two carotenoids, canthaxanthin and β-apo-8″-carotenal, with no affinity for the TCDD binding site. Biochemical pharmacology, 54 (2), 307–315.
   PubMed Web of Science ®Google Scholar
• Guinedi, A.S., et al., 2005. Preparation and evaluation of reverse-phase evaporation and multilamellar niosomes as ophthalmic carriers of acetazolamide. International journal of pharmaceutics, 306 (1–2), 71–82.
   PubMed Web of Science ®Google Scholar
• Hao, Y.-M. and Li, K.A., 2011. Entrapment and release difference resulting from hydrogen bonding interactions in niosome. International journal of pharmaceutics, 403 (1–2), 245–253.
   PubMed Web of Science ®Google Scholar
• Hu, C. and Rhodes, D.G., 1999. Proniosomes: a novel drug carrier preparation. International journal of pharmaceutics, 185 (1), 23–35.
   PubMed Web of Science ®Google Scholar
• Jadon, P.S., et al., 2009. Enhanced oral bioavailability of griseofulvin via niosomes. AAPS pharmscitech, 10 (4), 1186.
   PubMed Web of Science ®Google Scholar
• Jiang, J., et al., 2013. Indole-3-carbinol inhibits LPS-induced inflammatory response by blocking TRIF-dependent signaling pathway in macrophages. Food and chemical toxicology, 57, 256–261.
   PubMed Web of Science ®Google Scholar
• Kamaly, N., et al., 2012. Targeted polymeric therapeutic nanoparticles: design, development and clinical translation. Chemical society reviews, 41 (7), 2971–3010.
   PubMed Web of Science ®Google Scholar
• Kataria, S., et al., 2011. Stealth liposomes: a review. International journal of research in ayurveda & pharmacy, 2 (5), 1534–1538.
   Google Scholar
• Kazi, K.M., et al., 2010. Niosome: a future of targeted drug delivery systems. Journal of advanced pharmaceutical technology & research, 1, 374.
   PubMedGoogle Scholar
• Kumar, G.P. and Rajeshwarrao, P., 2011. Nonionic surfactant vesicular systems for effective drug delivery – an overview. Acta pharmaceutica sinica B, 1 (4), 208–219.
   Web of Science ®Google Scholar
• Li, Y., et al., 2011. Exogenous stimuli maintain intraepithelial lymphocytes via aryl hydrocarbon receptor activation. Cell, 147 (3), 629–640.
   PubMed Web of Science ®Google Scholar
• Marconett, C.N., et al., 2010. Indole-3-carbinol triggers aryl hydrocarbon receptor-dependent estrogen receptor (ER) α protein degradation in breast cancer cells disrupting an ERα-GATA3 transcriptional cross-regulatory loop. Molecular biology of the Cell, 21 (7), 1166–1177.
   PubMed Web of Science ®Google Scholar
• Marianecci, C., et al., 2014. Niosomes from 80s to present: the state of the art. Advances in Colloid and interface science, 205, 187–206.
   PubMed Web of Science ®Google Scholar
• Mcmahon, G., et al., 2014. Phenotype refinement strengthens the association of AHR and CYP1A1 genotype with caffeine consumption. Plos one, 9 (7), e103448.
   PubMed Web of Science ®Google Scholar
• Micka, J., et al., 1997. Human Ah receptor (AHR) gene: localization to 7p15 and suggestive correlation of polymorphism with CYP1A1 inducibility. Pharmacogenetics, 7 (2), 95–101.
   PubMedGoogle Scholar
• Moghassemi, S. and Hadjizadeh, A., 2014. Nano-niosomes as nanoscale drug delivery systems: an illustrated review. Journal of controlled release: official journal of the controlled release society, 185, 22–36.
   PubMed Web of Science ®Google Scholar
• Mohammadi, S., et al., 2017a. Effects of berberine on the secretion of cytokines and expression of genes involved in cell cycle regulation in THP-1 monocytic cell line. Iranian journal of basic medical sciences, 20, 530.
   PubMed Web of Science ®Google Scholar
• Mohammadi, S., et al., 2017b. Indole-3-carbinol induces G1 cell cycle arrest and apoptosis through aryl hydrocarbon receptor in THP-1 monocytic cell line. Journal of receptors and signal transduction, 37 (5), 506–514.
   PubMed Web of Science ®Google Scholar
• Mokhtar, M., et al., 2008. Effect of some formulation parameters on flurbiprofen encapsulation and release rates of niosomes prepared from proniosomes. International journal of pharmaceutics, 361 (1–2), 104–111.
   PubMed Web of Science ®Google Scholar
• Murray, I.A., Patterson, A.D., and Perdew, G.H., 2014. Aryl hydrocarbon receptor ligands in cancer: friend and foe. Nature reviews cancer, 14 (12), 801.
   PubMed Web of Science ®Google Scholar
• Najlah, M., et al., 2015. A facile approach to manufacturing non-ionic surfactant nanodipsersions using proniosome technology and high-pressure homogenization. Journal of liposome research, 25 (1), 32–37.
   PubMed Web of Science ®Google Scholar
• Nasr, M., et al., 2008. Vesicular aceclofenac systems: a comparative study between liposomes and niosomes. Journal of microencapsulation, 25 (7), 499–512.
   PubMed Web of Science ®Google Scholar
• Nebert, D.W., et al., 2004. Role of aryl hydrocarbon receptor-mediated induction of the CYP1 enzymes in environmental toxicity and cancer. Journal of biological chemistry, 279 (23), 23847–23850.
   PubMed Web of Science ®Google Scholar
• Pardakhty, A., et al., 2011. Pharmacokinetic study of niosome-loaded insulin in diabetic rats. DARU journal of pharmaceutical sciences, 19, 404.
   Google Scholar
• Park, E., et al., 2007. Optimized THP-1 differentiation is required for the detection of responses to weak stimuli. Inflammation research, 56 (1), 45–50.
   PubMed Web of Science ®Google Scholar
• Rasband, W. S., 1997–2018. ImageJ. Bethesda, Maryland: U. S. National Institutes of Health. Available from: http://imagej.nih.gov/ij/.
   Google Scholar
• Ruckmani, K. and Sankar, V., 2010. Formulation and optimization of zidovudine niosomes. Aaps pharmscitech, 11 (3), 1119–1127.
   PubMed Web of Science ®Google Scholar
• Saki, A., Tabesh, H., and Khalili, S., 2013. Determining the direct and indirect effect of number of articles and citations on h-index among Iranian researchers. World journal of pharmaceutical research 3 (1), 207–210.
   Google Scholar
• Steinmetz, K.A. and Potter, J.D., 1996. Vegetables, fruit, and cancer prevention: a review. Journal of the American dietetic association, 96 (10), 1027–1039.
   PubMed Web of Science ®Google Scholar
• Stockinger, B., et al., 2014. The aryl hydrocarbon receptor: multitasking in the immune system. Annual review of immunology, 32 (1), 403–432.
   PubMed Web of Science ®Google Scholar
• Sultan, A.A., et al., 2018. Niosomes for oral delivery of nateglinide: in situ-in vivo correlation. Journal of liposome research, 28 (3), 209–217.
   PubMed Web of Science ®Google Scholar
• Thakkar, M. and Brijesh, S., 2018. Physicochemical investigation and in vivo activity of anti-malarial drugs co-loaded in Tween 80 niosomes. Journal of liposome research, 28 (4), 315–321.
   PubMed Web of Science ®Google Scholar
• Tibbitt, M.W., Dahlman, J.E., and Langer, R., 2016. Emerging frontiers in drug delivery. Journal of the American chemical society, 138 (3), 704–717.
   PubMed Web of Science ®Google Scholar
• Uyttenhove, C. and Van Snick, J., 2006. Development of an anti‐IL‐17A auto‐vaccine that prevents experimental auto‐immune encephalomyelitis. European journal of immunology, 36 (11), 2868–2874.
   PubMed Web of Science ®Google Scholar
• Veldhoen, M., et al., 2008. The aryl hydrocarbon receptor links T H 17-cell-mediated autoimmunity to environmental toxins. Nature, 453 (7191), 106.
   PubMed Web of Science ®Google Scholar
• Vrzal, R., et al., 2005. Activation of the aryl hydrocarbon receptor by berberine in HepG2 and H4IIE cells: Biphasic effect on CYP1A1. Biochemical pharmacology, 70 (6), 925–936.
   PubMed Web of Science ®Google Scholar
• Vyas, S., et al., 2005. Non-ionic surfactant based vesicles (niosomes) for non-invasive topical genetic immunization against hepatitis B. International journal of pharmaceutics, 296 (1–2), 80–86.
   PubMed Web of Science ®Google Scholar
• Williams, H.D., et al., 2013. Strategies to address low drug solubility in discovery and development. Pharmacological reviews, 65 (1), 315–499.
   PubMed Web of Science ®Google Scholar
• Yazdani, Y., et al., 2011. Expression of an innate immune element (mouse hepcidin-1) in baculovirus expression system and the comparison of its function with synthetic human hepcidin-25. Iranian journal of pharmaceutical research, 10, 55.
   Web of Science ®Google Scholar